Puma Biotechnology (PBYI) Retained Earnings (2010 - 2026)
Puma Biotechnology (PBYI) posted Retained Earnings of -$31000.0 for Q1 2026, down 186.11% on a QoQ basis from $36000.0 in Q4 2025, and up 100.0% year-over-year from -$15500.2 in Q1 2025.
Puma Biotechnology (PBYI) Retained Earnings (2010 - 2026) Analysis & Trends
Puma Biotechnology's Retained Earnings history runs 17 years deep, the most recent figure standing at -$31000.0 for Q1 2026.
- Quarterly Retained Earnings rose 100.0% year-over-year to -$31000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$31000.0 (up 100.0% YoY) and the FY2025 annual result came in at $36000.0, up 100.0% from the prior year.
- Retained Earnings was -$31000.0 for Q1 2026 at Puma Biotechnology, down from $36000.0 in the prior quarter.
- Across five years, Retained Earnings topped out at $36000.0 in Q4 2025 and bottomed at -$1.4 billion in Q1 2022.
- A 5-year average of -$894.7 million and a median of -$1.3 billion in 2024 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings tumbled 136078800.0% — and 2025, when it jumped 100.0%.
- Puma Biotechnology's Retained Earnings stood at -$1.4 billion in 2022, then climbed by 1.15% to -$1.3 billion in 2023, then climbed by 2.25% to -$1.3 billion in 2024, then soared by 100.0% to $36000.0 in 2025, then tumbled by 186.11% to -$31000.0 in 2026.
- Business Quant data shows PBYI's Retained Earnings at -$31000.0 in Q1 2026, $36000.0 in Q4 2025, and $19000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Puma Biotechnology | 407.27 Mn | 368.99 Mn | 34.39 Mn | -31,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -31,000.00 |
| Dec 31, 2025 | 36,000.00 |
| Sep 30, 2025 | 19,000.00 |
| Jun 30, 2025 | -1.31 Bn |
| Mar 31, 2025 | -1.31 Bn |
| Dec 31, 2024 | -1.31 Bn |
| Sep 30, 2024 | -1.33 Bn |
| Jun 30, 2024 | -1.35 Bn |
| Mar 31, 2024 | -26,000.00 |
| Dec 31, 2023 | -1.35 Bn |
| Sep 30, 2023 | -1.36 Bn |
| Jun 30, 2023 | -6,000.00 |
| Mar 31, 2023 | -1.37 Bn |
| Jun 30, 2022 | -1.36 Bn |
| Mar 31, 2022 | -1.37 Bn |
| Dec 31, 2021 | -1.37 Bn |
| Sep 30, 2021 | -1.37 Bn |
| Jun 30, 2021 | -1,000.00 |
| Mar 31, 2021 | -1.32 Bn |
| Sep 30, 2020 | -1.32 Bn |